FIELD: medicine, pharmacy, pharmaceutical technology.
SUBSTANCE: invention relates to an antibacterial preparation azithromycin. The stable pharmaceutical suspension of azithromycin comprises the therapeutically effective dose of azithromycin and special additives - sorbitol, sodium benzoate, aromatic principles, glycerol, glutamic acid, methylcellulose, polyvinylpyrrolidone and propylene glycol. Also, invention proposes a method for preparing the stable suspension of azithromycin that involves addition of mixture of azithromycin with glutamic acid as solution in glycerol or as dry form to an aqueous solution of methylcellulose containing propylene glycol and glycerol or propylene glycol and successively dissolved sodium benzoate, polyvinylpyrolidone and sorbitol followed by dilution with water up to the azithromycin concentration that is necessary for using. Invention provides creature of new stable suspension that is resistant for 1 year, not less, and useful for treatment of children being among them suffering with diabetes mellitus.
EFFECT: improved method for preparing, valuable medicinal properties of suspension.
4 cl, 4 tbl, 1 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
BROMHEXINE SYRUP | 2001 |
|
RU2190396C1 |
ANTIMICROBIAL PHARMACEUTICAL COMPOSITION | 2002 |
|
RU2237478C2 |
SYRUP PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING THEREOF | 2009 |
|
RU2410088C2 |
ANALGESIC AND ANTIPYRETIC PHARMACEUTICAL COMPOSITION AND METHOD FOR PREPARING THEREOF | 2009 |
|
RU2406494C1 |
DEANOL ACEGLUMATE DEMONSTRATING ANTIULCEROGENIC, GASTROPROTECTIVE AND ENTEROPROTECTIVE ACTIVITY, COMBINATION POSSESSING ANTIULCEROGENIC, GASTROPROTECTIVE AND ENTEROPROTECTIVE ACTIVITY (VERSIONS), PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2435575C2 |
LIQUID PHARMACEUTICAL COMPOSITION (VERSIONS) AND METHOD FOR PHOSPHOR BINDING IN GASTROINTESTINAL TRACT | 2007 |
|
RU2463060C2 |
COMPOSITIONS OF ANTIBIOTIC | 2004 |
|
RU2376980C2 |
PHARMACEUTICAL COMPOSITION POSSESSING ANTIINFLAMMATORY, BRONCHOLYTIC, ANTI-TUBERCULOSIS ACTIVITY | 2011 |
|
RU2448961C1 |
AMBROXOL SYRUP FOR TREATMENT OF PATIENTS WITH BRONCHOPULMONAL DISEASES | 2000 |
|
RU2169557C1 |
PHARMACEUTICAL COMPOSITION ELICITING HEPATOPROTECTIVE EFFECT AND MEDICINAL AGENT | 2003 |
|
RU2257208C1 |
Authors
Dates
2005-07-10—Published
2003-10-14—Filed